Home
Integrated Core Strategies reported a 5.7% stake in Karyopharm Therapeutics KPTI · 1,297,297 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.7%
- Last report
- 2.3% · filed 26/04/13
- Shares held
- 1,297,297 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/08/31
- Filed
- 26/09/04
5.7% stake · +3.4pp from the last report
- Stake
- 5.7%
- Last report
- 2.3%
- Since last report
- +3.4pp
Karyopharm Therapeutics trades, last 26 weeks
What else happened in Karyopharm Therapeutics around then
Filed or reported within 30 days of the trade day · 08/01~09/30Integrated Core Strategies's other 5% stake reports
- Integrated Core Strategies
5% stakeBetter Home & Finance Holding
5% stakeBetter Home & Finance Holding
BETR
5.5% stake
730,265 sh
5.5% stake
Filed 09/22
- Integrated Core Strategies
5% stakeFortress Biotech
5% stakeFortress Biotech
FBIO
5.3% stake
1,778,561 sh
5.3% stake
Filed 09/01
- Integrated Core Strategies
5% stakeTenaya Therapeutics
5% stakeTenaya Therapeutics
TNYA
5.2% stake
11,581,565 sh
5.2% stake
Filed 08/24
- Integrated Core Strategies
5% stakeCollegium Pharmaceutical
5% stakeCollegium Pharmaceutical
COLL
5.6% stake
1,820,330 sh
5.6% stake
Filed 08/24
- Integrated Core Strategies
5% stakeSharonAI Holdings
5% stakeSharonAI Holdings
SHAZ
4.8% stake
1,742,894 sh
4.8% stake
Filed 08/14
